Xanthate will lead beneficiation reagents sales through 2036 with 35.0% of the product segment in 2026. The market was valued at USD 9.1 billion in 2025 and is projected to grow from USD 9.7 billion in 2026 to USD 17.8 billion by 2036, creating an incremental opportunity of USD 8.7 billion.